Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Ltd has strengthened its financials by issuing 2,131,404 new shares from option exercises, accumulating $639,421 to bolster its cash balance as FY24 closes. The company has seen two consecutive cash flow positive quarters and anticipates a third, with plans to unveil the Biome-27 Strategic Plan and FY25 strategy soon. Biome continues to focus on delivering health-improving biotherapeutics and complementary medicines, with a commitment to accessibility and supported by clinical research.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.
